Morgan Stanley Moon Lake Immunotherapeutics Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Morgan Stanley holds 47,144 shares of MLTX stock, worth $1.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,144

Previous 130,598 63.9%

Holding current value

$1.97 Million

Previous $6.58 Million 61.95%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$45.84 - $57.91 $3.83 Million - $4.83 Million	-83,454 Reduced 63.9%	47,144 $2.51 Million
Q3 2024 Nov 14, 2024	BUY	$40.15 - $55.4 $2.47 Million - $3.41 Million	61,571 Added 89.2%	130,598 $6.58 Million
Q2 2024 Oct 17, 2024	SELL	$38.43 - $48.6 $6.15 Million - $7.78 Million	-160,155 Reduced 69.88%	69,027 $3.04 Million
Q2 2024 Aug 14, 2024	SELL	$38.43 - $48.6 $6.15 Million - $7.78 Million	-160,155 Reduced 69.88%	69,027 $3.04 Million
Q1 2024 Oct 17, 2024	BUY	$43.78 - $63.86 $7.01 Million - $10.2 Million	160,155 Added 232.02%	229,182 $11.5 Million
Q1 2024 Aug 16, 2024	BUY	$43.78 - $63.86 $7.12 Million - $10.4 Million	162,668 Added 244.56%	229,182 $11.5 Million
Q1 2024 May 15, 2024	BUY	$43.78 - $63.86 $7.12 Million - $10.4 Million	162,668 Added 244.56%	229,182 $11.5 Million
Q4 2023 Aug 16, 2024	SELL	$36.35 - $63.02 $91,347 - $158,369	-2,513 Reduced 3.64%	66,514 $4.02 Million
Q4 2023 Feb 13, 2024	BUY	$36.35 - $63.02 $2.07 Million - $3.6 Million	57,063 Added 603.78%	66,514 $4.02 Million
Q3 2023 Nov 15, 2023	SELL	$48.35 - $61.26 $7.25 Million - $9.19 Million	-149,974 Reduced 94.07%	9,451 $538,000
Q2 2023 Aug 14, 2023	BUY	$19.01 - $51.79 $2.41 Million - $6.57 Million	126,906 Added 390.25%	159,425 $8.13 Million
Q1 2023 May 15, 2023	BUY	$11.03 - $23.7 $56,848 - $122,149	5,154 Added 18.83%	32,519 $695,000
Q4 2022 Feb 14, 2023	BUY	$7.05 - $10.5 $171,068 - $254,782	24,265 Added 782.74%	27,365 $287,000
Q3 2022 Nov 14, 2022	BUY	$5.25 - $9.27 $16,275 - $28,737	3,100 New	3,100 $24,000

Others Institutions Holding MLTX

# of Institutions

137

Shares Held

58.1M

Call Options Held

124K

Put Options Held

96.9K

View Full List

About MoonLake Immunotherapeutics

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $1.54B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

More about MLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account